Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Daybue™ (trofinetide) – New orphan drug approval
March 10, 2023 - Acadia Pharmaceuticals announced the FDA approval of Daybue (trofinetide), for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older.
